Private Wealth Management Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24K Hold
106
﹤0.01% 1263
2026
Q1
$1.78K Hold
106
﹤0.01% 1116
2025
Q4
$1.7K Hold
106
﹤0.01% 1136
2025
Q3
$1.31K Hold
106
﹤0.01% 1216
2025
Q2
$1.22K Buy
106
+30
+39% +$356 ﹤0.01% 1212
2025
Q1
$1.14K Hold
76
﹤0.01% 1226
2024
Q4
$1.32K Hold
76
﹤0.01% 1223
2024
Q3
$1.41K Hold
76
﹤0.01% 1191
2024
Q2
$1.54K Hold
76
﹤0.01% 1147
2024
Q1
$1.3K Buy
+76
New +$1.2K ﹤0.01% 1157

Other funds holding CLB

Private Wealth Management Group's CLB Position: Q2 2026 in Review

Private Wealth Management Group held its Core Laboratories (CLB) position steady in Q2 2026 at 106 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1263.

Private Wealth Management Group first reported a position in CLB in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.78K in Q1 2026. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Private Wealth Management Group held 106 shares of Core Laboratories worth $1.24K as of Q2 2026.
  • Private Wealth Management Group left its Core Laboratories share count unchanged in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1263 holding.
  • Private Wealth Management Group first reported a position in Core Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Private Wealth Management Group's Core Laboratories position peaked at $1.78K in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.